The $1.7 million grant will help scientists with expertise in artificial intelligence and machine learning to address complex biomedical challenges in nutrition and health.
Applications are open for Rare and Distinctive Language Fellowships, which offer students intensive summer study in modern languages that are not commonly taught, including Zulu, Finnish, Yiddish, Sinhala, Tibetan and Burmese.
Purple bacteria is one of the primary contenders for life that could dominate a variety of Earth-like planets orbiting different stars, and would produce a distinctive "light fingerprint," Cornell scientists report.
The CU Downtown event, a celebration to welcome new students, has merged with Ithaca College and Tompkins Cortland Community College for the first time to create one grand event for 2023: Welcome Student Weekend.
This year's L. Michael Goldsmith Lecture returns to New York City on April 19 and will be given by Mexico City-based architect Tatiana Bilbao. In advance of the event, Bilbao shares insight into her approach to design and the priorities that drive her practice.
The inaugural Northeastern Dairy Product Innovation Competition is now accepting applications, providing an opportunity for producers of value-added dairy products to bring their innovations to market.
Throughout history, sonar’s distinctive “ping” has been used to map oceans, spot enemy submarines and find sunken ships. Today, a variation of that technology – in miniature form, developed by Cornell researchers – is proving a game-changer in wearable body-sensing technology.
Weill Cornell Medicine associate professor Gregory F. Sonnenberg has been awarded a five-year, $3.26 million grant from the National Institutes of Health to investigate the underlying mechanisms of inflammatory bowel disease.
For its work supporting international scholars whose work puts them at risk in their home countries, Cornell has been awarded the Institute of International Education’s Centennial Medal. It was presented to Provost Michael I. Kotlikoff on Oct. 30.
Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis drug development.